Detailed product information, standard pack sizes and direct quote request for analytical and research use.
| Product Name | Palbociclib |
|---|---|
| CAT No. | HX-T-38566 |
| CAS No. | 571190-30-2 |
| Category | Api Standards |
| Parent API | Palbociclib |
| Molecular Formula | C₂₄H₂₉N₇O₂ |
| Molecular Weight | 447.53 |
| Stock Status | In Stock |
| Application | Palbociclib (also known as compound number ) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
Palbociclib is listed under Api Standards and may be used for analytical research, method development, method validation, impurity profiling and routine quality control workflows. Documentation such as COA and MSDS can be requested during enquiry.